Ruxolitinib is a drug that treats myelofibrosis, polycythemia vera, and hydroxyurea. It is available in tablet form and is taken two times a day. It starts with low doses and gradually increases the dose. Some side effects of Ruxolitinib are shortness of breath, weight gain, diarrhea, constipation, nausea, and vomiting.
Hello, Welcome to icliniq.com. Thank you for your query. I understand your concern. Myeloproliferative neoplasms (MPN) are a heterogeneous group of disorders of the hematopoietic stem cells.
Disclaimer: No content published on this website is intended to be a substitute for professional medical diagnosis, advice or treatment by a trained physician. Seek advice from your physician or other qualified healthcare providers with questions you may have regarding your symptoms and medical condition for a complete medical diagnosis. Do not delay or disregard seeking professional medical advice because of something you have read on this website. Read our Editorial Process to know how we create content for health articles and queries.
